Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mooi

Showing results (81-90 of 170) with videos related to

Pageof 17
Sort By:
Vaccine|June 2, 1998
The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse modelR J Willems, J Kamerbeek, C A Geuijen, et al.
The Journal of Infectious Diseases|April 1, 1995
Bordetella pertussis fimbriae bind to human monocytes via the minor fimbrial subunit FimDW L Hazenbos, C A Geuijen, B M van den Berg, et al.
Clinical and Vaccine Immunology : CVI|January 5, 2007
Effects of a diphtheria-tetanus-acellular pertussis vaccine on immune responses in murine local lymph node and lung allergy modelsRob J Vandebriel, Eric R Gremmer, Michiel van Hartskamp, et al.
Infection and Immunity|July 12, 2001
Immunoglobulin A-mediated protection against Bordetella pertussis infectionS M Hellwig, A B van Spriel, J F Schellekens, et al.
Journal of Bacteriology|August 10, 1999
Moraxella (Branhamella) catarrhalis BRO beta-lactamase: a lipoprotein of gram-positive origin?H J Bootsma, P C Aerts, G Posthuma, et al.
The Journal of Infectious Diseases|April 14, 2000
Analysis of Moraxella catarrhalis by DNA typing: evidence for a distinct subpopulation associated with virulence traitsH J Bootsma, H G van der Heide, S van de Pas, et al.
Infection and Immunity|February 7, 1998
Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolutionF R Mooi, H van Oirschot, K Heuvelman, et al.
Scandinavian Journal of Infectious Diseases|October 11, 2007
Antibody responses to defined regions of the Bordetella pertussis virulence factor pertactinMarcel Hijnen, Qiushui He, Rutger Schepp, et al.
FEMS Immunology and Medical Microbiology|November 22, 2011
Characterization of Bordetella holmesii isolates from patients with pertussis-like illness in The NetherlandsFrits R Mooi, Sylvia Bruisten, Ineke Linde, et al.
Infection and Immunity|November 1, 1994
Virulence factors determine attachment and ingestion of nonopsonized and opsonized Bordetella pertussis by human monocytesW L Hazenbos, B M van den Berg, J W van't Wout, et al.
Pageof 17

Showing results (81-90 of 170) with videos related to

Sort By:
Pageof 17
Vaccine|June 2, 1998
The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse modelR J Willems, J Kamerbeek, C A Geuijen, et al.
The Journal of Infectious Diseases|April 1, 1995
Bordetella pertussis fimbriae bind to human monocytes via the minor fimbrial subunit FimDW L Hazenbos, C A Geuijen, B M van den Berg, et al.
Clinical and Vaccine Immunology : CVI|January 5, 2007
Effects of a diphtheria-tetanus-acellular pertussis vaccine on immune responses in murine local lymph node and lung allergy modelsRob J Vandebriel, Eric R Gremmer, Michiel van Hartskamp, et al.
Infection and Immunity|July 12, 2001
Immunoglobulin A-mediated protection against Bordetella pertussis infectionS M Hellwig, A B van Spriel, J F Schellekens, et al.
Journal of Bacteriology|August 10, 1999
Moraxella (Branhamella) catarrhalis BRO beta-lactamase: a lipoprotein of gram-positive origin?H J Bootsma, P C Aerts, G Posthuma, et al.
The Journal of Infectious Diseases|April 14, 2000
Analysis of Moraxella catarrhalis by DNA typing: evidence for a distinct subpopulation associated with virulence traitsH J Bootsma, H G van der Heide, S van de Pas, et al.
Infection and Immunity|February 7, 1998
Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolutionF R Mooi, H van Oirschot, K Heuvelman, et al.
Scandinavian Journal of Infectious Diseases|October 11, 2007
Antibody responses to defined regions of the Bordetella pertussis virulence factor pertactinMarcel Hijnen, Qiushui He, Rutger Schepp, et al.
FEMS Immunology and Medical Microbiology|November 22, 2011
Characterization of Bordetella holmesii isolates from patients with pertussis-like illness in The NetherlandsFrits R Mooi, Sylvia Bruisten, Ineke Linde, et al.
Infection and Immunity|November 1, 1994
Virulence factors determine attachment and ingestion of nonopsonized and opsonized Bordetella pertussis by human monocytesW L Hazenbos, B M van den Berg, J W van't Wout, et al.
Pageof 17